Rs. An IPO with a face value of Rs. 800 crore in fresh issue and through promoters and existing investors of Rs. 2,200 crore is a mix of sales offers. Under the OFS, Bupa Singapore Holdings and Fatal Tone will divest their stake.
The company, in consultation with the book-running lead manager, made a pre-IPO placement of Rs. 160 crore may consider an issue of specified securities. If such placement is completed, the size of the fresh issue will be reduced.
About 75% of the offering is reserved for qualified institutional buyers, 15% for non-institutional investors and the remaining 10% for retail investors.
The company raised Rs. 625 intends to use the net proceeds to strengthen its solvency level and increase its capital base for general corporate purposes.
Niva Bupa Health Insurance Company is one of the largest and fastest growing Standalone Retail Health Insurers (SAHI) in India with a turnover of Rs. 5,499.43 crore has a gross direct written premium (GDPI). Based on Retail Health GDPI, it had a market share of 16.24% in the Indian Sahi market for FY24.
As of March 2024, Niva Bupa has insured 14.73 million lives. According to the Redseer report, Niva Bupa’s overall direct sales channel was the highest among SAHIs in terms of total health GDPI contribution in FY 2024.
Also Read: Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue
Its gross written premium in FY2024 will grow to Rs. 528 crore to Rs. 733 crore has happened.
The company has expanded its network of hospitals from 8,562 in March 2022 to 10,460 by March 2024, with one of the largest networks providing cashless treatment. Among these, 326 are Preferred Partner Network (PPN) hospitals, which offer additional benefits such as free ambulance services, designated relationship managers, and discounts on pharmacy, diagnostics and consultations even after discharge.
ICICI Securities, Morgan Stanley India, Kotak Mahindra Capital, Axis Capital, HDFC Bank and Motilal Oswal Investment Advisors are the book-running lead managers for the IPO and KFin Technologies is the offer registrar.
Meanwhile, Segility India, one of the largest technology-enabled, pure-play healthcare focused solutions and service providers, has also filed its draft papers for an IPO.
per equity share Rs. The IPO with a face value of 10 is an offer for sale of up to 98.4 crore equity shares in its entirety by the promoter selling shareholder Sagility BV. Offer includes reservation for subscription by eligible employees.
About 75% of the offering is reserved for qualified institutional buyers, 15% for non-institutional investors and the remaining 10% for retail investors.
Founded in 2021, the Bengaluru-based company provides technology-based services to both payers and providers, covering core benefits administration and clinical services.
(You can now subscribe to our ETMarkets WhatsApp channel)
